News from Cytochroma A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Jan 09, 2013, 10:46 ET OPKO Health s'apprête à acquérir la société privée Cytochroma

Cette acquisition inclut les produits candidats ReplideaTM et AlpharenTM, tous deux en essais cliniques de phase 3 chez des patients souffrant...


Jan 09, 2013, 09:01 ET OPKO Health kauft das Privatunternehmen Cytochroma auf

Die Übernahme schließt Replidea[TM] und Alpharen[TM] ein, beides klinische Phase-3-Studien an Patienten mit Nierenerkrankungen Das...


Jan 08, 2013, 18:01 ET OPKO Health to acquire privately held Cytochroma

Acquisition Includes ReplideaTM and AlpharenTM, Both in Phase 3 Clinical Trials with Kidney Disease Patients MARKHAM, ON, Jan. 8, 2013...


Sep 21, 2012, 00:19 ET Cytochroma initiiert Phase 3 der Studie für CTAP101-Kapseln zur Behandlung von Patienten mit chronischen Nierenerkrankungen

Cytochroma meldete heute die Einleitung einer Studie der Phase 3 für CTAP101-Kapseln ("CTAP101-Kapseln") für die Behandlung von...


Sep 21, 2012, 00:17 ET Cytochroma amorce une étude de phase 3 concernant l'utilisation des Gélules CTAP101 chez les patients souffrant de maladie rénale chronique

Cytochroma a annoncé aujourd'hui le lancement d'une étude de phase 3 concernant les gélules CTAP101 (« Gélules...


Sep 20, 2012, 09:00 ET Cytochroma Initiates Phase 3 Study of CTAP101 Capsules in Chronic Kidney Disease Patients

MARKHAM, ON, Sept. 20, 2012 /PRNewswire/ - Cytochroma today announced the initiation of a phase 3 study of CTAP101 capsules ("CTAP101 Capsules")...


Jun 01, 2012, 08:00 ET Cytochroma Regains Rights to Lunacalcipol

MARKHAM, ON, June 1, 2012 /PRNewswire/ - Cytochroma today announced that it has regained the rights to all indications in the United States (US)...


May 11, 2012, 08:00 ET Cytochroma announces positive Phase 2b results for CTAP101 Capsules at National Kidney Foundation Meeting

MARKHAM, ON, May 11, 2012 /PRNewswire/ - Cytochroma today announced positive clinical trial results for its lead product, CTAP101 Capsules. ...


Apr 03, 2012, 08:00 ET Cytochroma receives notice of allowance for US patent covering CTAP101 capsules

MARKHAM, ON, April 3, 2012 /PRNewswire/ - Cytochroma today announced that the United States Patent and Trademark Office (USPTO) issued a Notice...


Feb 29, 2012, 08:00 ET Cytochroma to present at the Cowen and Company 32nd Annual Healthcare Conference

MARKHAM, ON, Feb. 29, 2012 /PRNewswire/ - Cytochroma today announced that Dr. Charles W. Bishop, Cytochroma's President and Chief Executive...


Oct 03, 2011, 08:00 ET Cytochroma announces new appointment to its Board of Directors

MARKHAM, ON, Oct. 3, 2011 /PRNewswire/ - Cytochroma today announced the appointment of Ms. Lily Lam to its Board of Directors.  Ms. Lam...


Sep 07, 2011, 08:00 ET Cytochroma to present at upcoming investor conferences

MARKHAM, ON, Sept. 7, 2011 /PRNewswire/ - Cytochroma today announced that the Company will be presenting a corporate overview at the following...


Jul 26, 2011, 12:00 ET Cytochroma announces $1 million investment by Ontario's Investment Accelerator Fund

MARKHAM, ON, July 26, 2011 /PRNewswire/ - Cytochroma today announced that it has closed an equity investment of $1 million from the Investment...


Jun 13, 2011, 08:00 ET CYTOCHROMA ANNOUNCES NEW APPOINTMENTS TO ITS BOARD OF DIRECTORS

MARKHAM, ON, June 13, 2011 /PRNewswire/ - Cytochroma today announced the appointment of Dr. Cynthia Lavoie and Mr. Osamu Otani to its Board of...


Feb 17, 2011, 08:00 ET CYTOCHROMA INITIATES PHASE 2B STUDY OF CTAP101 CAPSULES IN CHRONIC KIDNEY DISEASE PATIENTS

MARKHAM, ON, Feb. 17 /PRNewswire/ - Cytochroma today announced the initiation of a repeat-dose safety and efficacy study of CTAP101 Capsules in...


Nov 18, 2010, 08:00 ET CYTOCHROMA ANNOUNCES DATA PRESENTATIONS AT AMERICAN SOCIETY OF NEPHROLOGY'S 43RD ANNUAL MEETING AND SCIENTIFIC EXPOSITION

MARKHAM, ON, Nov. 18 /PRNewswire/ - Cytochroma today announced that data on several of its product candidates will be presented at the American...


Sep 08, 2010, 08:00 ET CYTOCHROMA TO PRESENT AT UPCOMING INVESTOR CONFERENCES

MARKHAM, ON, Sept. 8 /PRNewswire/ - Cytochroma today announced that Charles W. Bishop, PhD, President and CEO, will be presenting a corporate...


Jun 15, 2010, 08:00 ET Cytochroma announces new findings on vitamin D catabolic enzyme and kidney disease published in Kidney International

- Dysregulation of CYP24 linked to chronic kidney disease - MARKHAM, ON, June 15 /PRNewswire/ - Cytochroma today announced the publication of...


May 25, 2010, 08:00 ET Cytochroma announces positive Phase 1/2 results for CTAP101 capsules in non-dialysis chronic kidney disease patients

MARKHAM, ON, May 25 /PRNewswire/ - Cytochroma today announced positive Phase 1/2 results for CTAP101 Capsules, a product being developed to treat...


May 06, 2010, 08:00 ET Cytochroma announces positive Phase I results for CTAP201 Injection in hemodialysis patients

MARKHAM, ON, May 6 /PRNewswire/ - Cytochroma today announced positive Phase I results for CTAP201 Injection, a product being developed to treat...


Nov 25, 2009, 08:00 ET Cytochroma Announces Appointment of Peter Moldt to Board of Directors

MARKHAM, ON, Nov. 25 /PRNewswire/ - Cytochroma today announced the appointment of Peter Moldt, PhD to its Board of Directors. Dr. Moldt will...


Oct 15, 2009, 08:00 ET Cytochroma Appoints Dr. John Cunningham to its Scientific Advisory Board

MARKHAM, ON, Oct. 15 /PRNewswire/ - Cytochroma today announced that it has appointed John Cunningham, CVO, BM BCh, DM, FRCP, to the Company's...


Sep 02, 2009, 08:00 ET Cytochroma to Present at Two Upcoming Investor Conferences

MARKHAM, ON, Sept. 2 /PRNewswire/ - Cytochroma today announced that Charles W. Bishop, PhD, President and CEO, will be presenting a corporate...


Jul 15, 2009, 08:00 ET Cytochroma initiates pharmacokinetic study of CTAP101 Capsules in chronic kidney disease patients

MARKHAM, ON, July 15 /PRNewswire/ - Cytochroma today announced the initiation of a pharmacokinetic study of CTAP101 Capsules in patients with...


Mar 26, 2009, 08:00 ET Cytochroma to present at BioCentury's 2009 Future Leaders in the Biotech Industry Conference

MARKHAM, ON, March 26 /PRNewswire/ - Cytochroma Inc. today announced that Charles W. Bishop, PhD, President and CEO, will be presenting a...